Interleukin-6 is key to cancer stem cells' effects (IMAGE)

Hokkaido University

Interleukin-6 is key to cancer stem cells' effects

Caption

When cancer stem cells modified to be unable to express interleukin-6 (8B-IL-6-KO) were transplanted into immunocompetent mice (C57BL/6), survival times of the mice increased significantly compared to mice that were transplanted with cancer stem cells that express IL-6 (8B-mock). (Haruka Wada, et al. Journal for ImmunoTherapy of Cancer. November 8, 2023) 

Credit

Haruka Wada, et al. Journal for ImmunoTherapy of Cancer. November 8, 2023

Usage Restrictions

This image may be used to report on this press release as long as the copyright holder is credited.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.